Ads
related to: acute myeloid leukemia treatment- Watch A Video On The MOA
Access Physician MOA Video
Materials On HCP Rx Site.
- Trasfusion Independence
Discover A Potential Treatment
Option For Your Patients.
- Management Considerations
Learn About Disease-Related Factors
Like Molecular Abnormalities.
- Physician Rx Resources
Find Clinical Resources, Videos,
And A HCP Testing Brochure.
- Testing For Mutations
Find Mutation Testing Information
For Your Patients With R/R AML.
- View Safety Profile
View The Safety Profile For
A R/R AML Treatment Option.
- Watch A Video On The MOA
Search results
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
NBC 10 - FOX 14 Monroe· 7 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML ...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 10 hours agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Medscape· 6 days agoIs the FDA Pressing Pause on More Cancer Trials? In October, the US Food and Drug Administration...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 3 days agoAfter re-manufacturing the lentivirus, Hemogenyx successfully addressed the FDA's concerns and...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 5 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 6 days agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 5 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers
MedPage Today· 6 days agoA strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...
Don't Miss the Dx: Woman Has Unintended Weight Loss, Fatigue
Medscape· 5 days agoAre you familiar with the presentation, workup, treatment, and monitoring of CML? Dr Adam Braun provides a brief guide.
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
KTLA-TV Los Angeles· 5 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results ...
Ads
related to: acute myeloid leukemia treatment